✦ LIBER ✦

Immune response to simultaneous administration of a recombinant DNA hepatitis B vaccine and multiple compulsory vaccines in infancy

✍ Scribed by Giuseppe Giammanco; Salvatore Li Volti; Luisa Mauro; Giuseppe Giammanco Bilancia; Isabella Salemi; Patrizia Barone; Salvatore Musumeci

Book ID: 119151082
Publisher: Elsevier Science
Year: 1991
Tongue: English
Weight: 363 KB
Volume: 9
Category: Article
ISSN: 0264-410X
DOI: 10.1016/0264-410x(91)90291-d

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of different dose levels and vac

Effects of different dose levels and vaccination schedules on immune response to a recombinant DNA hepatitis B vaccine in haemodialysis patients

✍ M. Bruguera; J.L. Rodicio; J.M. Alcazar; A. Oliver; G. Del Rio; R. Esteban-Mur 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 312 KB

The immune response of low dose recombin

The immune response of low dose recombinant DNA hepatitis B vaccine in teenagers in Singapore

✍ R. Guan; H.H. Tay; I. Yap; R. Smith; L.H. Tan 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 240 KB

OL-045 CpG DNA can enhance specific immu

OL-045 CpG DNA can enhance specific immune responses in mice immunized with recombinant hepatitis B surface antigen and hepatitis B vaccine

✍ P. He; X.C. Zhang; Z.Y. Hu; X.T. Wang; Z.L. Liang 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Further observations on the immune respo

Further observations on the immune response to recombinant hepatitis B vaccine after administration to Aboriginal and Torres Strait Island children

✍ JN HANNA; JL FAOAGALI; PJ BUDA; JW SHERIDAN 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 430 KB

Persistence of anti-HBs antibodies in he

Persistence of anti-HBs antibodies in health care personnel vaccinated with plasma-derived hepatitis B vaccine and response to recombinant DNA HB booster vaccine

✍ R. Trivello; M. Chiaramonte; T. Ngatchu; V. Baldo; S. Majori; M.E. Moschen; I. S 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 435 KB

Characterization of a human monoclonal a

Characterization of a human monoclonal antibody obtained after immunization with plasma vaccine and a booster with recombinant-DNA hepatitis B vaccine

✍ R.A. Heijtink; J. Kruining; P. van Bergen; S. de Rave; J. van Hattum; M. Schutte 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB

A human monoclonal antibody type IgG4, designated 1Ff4, was obtained by Epstein Barr virus transformation of peripheral blood lymphocytes from a hepatitis B vaccinee (HB-VAX: plasmaderived vaccine) after one boost of yeast recombinant DNA derived vaccine (Engerix-B). 1Ff4 binds preferentially to HBs